The unsolved relationship of brain aging and late-onset Alzheimer disease.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Biochimica et Biophysica Acta

• Publication date

  2009-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.bbagen.2009.07.016PMID 19632303
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain.

  2010cited by this paper
• Mini Mental State

  2010cited by this paper
• Amyloid beta mediates memory formation.

  2009cited by this paper
• Amyloid β-Protein Assembly and Alzheimer Disease*

  2009cited by this paper
• β-Amyloid Impairs AMPA Receptor Trafficking and Function by Reducing Ca2+/Calmodulin-dependent Protein Kinase II Synaptic Distribution*

  2009cited by this paper
• Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus

  2008cited by this paper
• Cholinergic Neuronal and Axonal Abnormalities Are Present Early in Aging and in Alzheimer Disease

  2008cited by this paper
• Glutamate receptor subunits expression in memory‐associated brain structures: Regional variations and effects of aging

  2008cited by this paper
• Ginkgo biloba for prevention of dementia: a randomized controlled trial.

  2008cited by this paper
• A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.

  2008cited by this paper
• Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.

  2008cited by this paper
• MRI correlates of neurofibrillary tangle pathology at autopsy

  2008cited by this paper
• Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels.

  2008cited by this paper
• Vitamin E for Alzheimer's disease and mild cognitive impairment.

  2008cited by this paper
• Oxidative stress increases levels of endogenous amyloid‐β peptides secreted from primary chick brain neurons

  2008cited by this paper
• Mitochondrially encoded cysteine predicts animal lifespan

  2008cited by this paper
• Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: Inverse correlation with Aβ levels

  2008cited by this paper
• Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium

  2008cited by this paper
• Peripheral Aβ subspecies as risk biomarkers of Alzheimer's disease

  2008cited by this paper
• Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis

  2008cited by this paper
• The coming acceleration of global population ageing

  2008cited by this paper
• Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease

  2008cited by this paper
• β‐amyloid burden is not associated with rates of brain atrophy

  2008cited by this paper
• Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors.

  2008cited by this paper
• Neuroscience: The plaque plan

  2008cited by this paper
• Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib.

  2008cited by this paper
• Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's‐disease‐model transgenic mice shown as by micromagnetic resonance imaging

  2008cited by this paper
• Activation of microglia with zymosan promotes excitatory amino acid release via volume‐regulated anion channels: the role of NADPH oxidases

  2008cited by this paper
• Cognitive-Behavioral Profiles of Neurodegenerative Dementias: Beyond Alzheimer's Disease

  2007cited by this paper
• Clinicopathologic Correlations in a Large Alzheimer Disease Center Autopsy Cohort: Neuritic Plaques and Neurofibrillary Tangles "Do Count" When Staging Disease Severity

  2007cited by this paper
• Clearance of amyloid-beta by circulating lipoprotein receptors.

  2007cited by this paper
• A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II.

  2007cited by this paper
• Clearance of amyloid-β by circulating lipoprotein receptors

  2007cited by this paper
• Memantine Treatment in Patients with Mild to Moderate Alzheimer's Disease: Results of a Randomised, Double-Blind, Placebo-Controlled 6-Month Study

  2007cited by this paper
• Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology.

  2007cited by this paper
• Amyloid precursor protein overexpression depresses excitatory transmission through both presynaptic and postsynaptic mechanisms

  2007cited by this paper
• Astrocytes aged in vitro show a decreased neuroprotective capacity

  2007cited by this paper
• Donepezil for Alzheimer's disease.

  2007cited by this paper
• Active γ-Secretase Complexes Contain Only One of Each Component*

  2007cited by this paper
• Partial Reduction of BACE1 Has Dramatic Effects on Alzheimer Plaque and Synaptic Pathology in APP Transgenic Mice*

  2007cited by this paper
• Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment.

  2007cited by this paper
• Antioxidant intake and cognitive function of elderly men and women: the Cache County Study.

  2007cited by this paper
• The amyloid code

  2006cited by this paper
• Neuronal neprilysin overexpression is associated with attenuation of Abeta-related spatial memory deficit.

  2006cited by this paper
• Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms

  2006cited by this paper
• Neural plasticity in the ageing brain

  2006cited by this paper
• Antioxidants as a potential therapy against age-related neurodegenerative diseases: amyloid Beta toxicity and Alzheimer's disease.

  2006cited by this paper
• Altered β‐secretase enzyme kinetics and levels of both BACE1 and BACE2 in the Alzheimer's disease brain

  2006cited by this paper
• Inhibition of hippocampal function in mild cognitive impairment: targeting the cholinergic hypothesis.

  2006cited by this paper
• Lipids and the pathogenesis of Alzheimer's disease: Is there a link?

  2006cited by this paper
• The development of amyloid beta protein deposits in the aged brain.

  2006cited by this paper
• Tumor Necrosis Factor-α Induces Neurotoxicity via Glutamate Release from Hemichannels of Activated Microglia in an Autocrine Manner*

  2006cited by this paper
• Synapse Formation and Function Is Modulated by the Amyloid Precursor Protein

  2006cited by this paper
• High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease

  2006cited by this paper
• Altered beta-secretase enzyme kinetics and levels of both BACE1 and BACE2 in the Alzheimer's disease brain.

  2006cited by this paper
• Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.

  2006cited by this paper
• Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment

  2006cited by this paper
• Down-regulation of Endogenous Amyloid Precursor Protein Processing due to Cellular Aging*

  2006cited by this paper
• Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.

  2006cited by this paper
• Decreased Expression and Activity of Neprilysin in Alzheimer Disease Are Associated With Cerebral Amyloid Angiopathy

  2006cited by this paper
• The glutamate story

  2006cited by this paper
• Association of metabolic syndrome with Alzheimer disease

  2006cited by this paper
• Amyloid load and cerebral atrophy in Alzheimer's disease: An 11C‐PIB positron emission tomography study

  2006cited by this paper
• Age-related changes in glutathione and glutathione-related enzymes in rat brain.

  2006cited by this paper
• Transgenic models of Alzheimer’s disease: Learning from animals

  2005cited by this paper
• Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors.

  2005cited by this paper
• β-Amyloid-Stimulated Microglia Induce Neuron Death via Synergistic Stimulation of Tumor Necrosis Factor α and NMDA Receptors

  2005cited by this paper
• Longer Forms of Amyloid β Protein: Implications for the Mechanism of Intramembrane Cleavage by γ-Secretase

  2005cited by this paper
• Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).

  2005cited by this paper
• Global prevalence of dementia: a Delphi consensus study

  2005cited by this paper
• Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's disease.

  2005cited by this paper
• Evidence of increased oxidative damage in subjects with mild cognitive impairment

  2005cited by this paper
• Paradigm shift in NMDA receptor antagonist drug development: Molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders

  2005cited by this paper
• Neprylisin decreases uniformly in Alzheimer's disease and in normal aging

  2005cited by this paper
• Age-associated changes in protein oxidation and proteasome activities in rat brain: modulation by antioxidants.

  2005cited by this paper
• The interaction of amyloid-beta with ApoE.

  2005cited by this paper
• Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase.

  2005cited by this paper
• Midlife cardiovascular risk factors and risk of dementia in late life

  2005cited by this paper
• Aging affects oxidative state in hippocampus, hypothalamus and adrenal glands of Wistar rats.

  2005cited by this paper
• Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease

  2005cited by this paper
• Oxidative stress potentiates BACE1 gene expression and Aβ generation

  2005cited by this paper
• Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo.

  2005cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Age-related changes of pyramidal cell basal dendrites in layers III and V of human motor cortex: A quantitative Golgi study

  2004cited by this paper
• β-Amyloid Peptides Induce Mitochondrial Dysfunction and Oxidative Stress in Astrocytes and Death of Neurons through Activation of NADPH Oxidase

  2004cited by this paper
• Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.

  2004cited by this paper
• Faculty Opinions recommendation of Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation.

  2004cited by this paper
• The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization

  2004cited by this paper
• Beta-secretase activity increases with aging in human, monkey, and mouse brain.

  2004cited by this paper
• Take five—BACE and the γ‐secretase quartet conduct Alzheimer's amyloid β‐peptide generation

  2004cited by this paper
• Memantine Improves Spatial Learning in a Transgenic Mouse Model of Alzheimer's Disease

  2004cited by this paper
• The importance of neuritic plaques and tangles to the development and evolution of AD

  2004cited by this paper
• Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease.

  2004cited by this paper
• Take five--BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation.

  2004cited by this paper
• Interaction Between Hypertension, apoE, and Cerebral White Matter Lesions

  2004cited by this paper
• Dissection of Amyloid-β Precursor Protein-dependent Transcriptional Transactivation*

  2004cited by this paper
• Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD

  2004cited by this paper
• Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.

  2003cited by this paper
• APP processing and synaptic function.

  2003cited by this paper
• Impact of aging on hippocampal function: plasticity, network dynamics, and cognition.

  2003cited by this paper

• L‐arginine metabolism ameliorates age‐related cognitive impairment by Amuc_1100‐mediated gut homeostasis maintaining

  2024cites this paper
• Cognitive training of mice attenuates age-related decline in associative learning and behavioral flexibility

  2024cites this paper
• In 2024, the amyloid-cascade-hypothesis still remains a working hypothesis, no less but certainly no more

  2024cites this paper
• Spatially resolved transcriptome of the aging mouse brain

  2024cites this paper
• Neuroprotective effects of Cubebin and Hinokinin lignan fractions of Piper cubeba fruit in Alzheimer’s disease in vitro model

  2023cites this paper
• Protective effect of Capsosiphon fulvescens on oxidative stress-stimulated neurodegenerative dysfunction of PC12 cells and zebrafish larva models

  2023cites this paper
• Posterior cingulate cortex reveals an expression profile of resilience in cognitively intact elders

  2022cites this paper
• The Binding of Different Substrate Molecules at the Docking Site and the Active Site of γ-Secretase Can Trigger Toxic Events in Sporadic and Familial Alzheimer’s Disease

  2022cites this paper
• Hyperactivation of monocytes and macrophages in MCI patients contributes to the progression of Alzheimer's disease

  2021cites this paper
• Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer’s Disease

  2021cites this paper
• Synthesis and Biological Evaluation of Benzimidazole Derivatives as Potential Neuroprotective Agents in an Ethanol-Induced Rodent Model.

  2021cites this paper
• NDT_A_264910 1311..1339

  2021cites this paper
• Immunosenescence and Alzheimer’s Disease

  2021cites this paper
• High-Throughput Metabolomics for Discovering Potential Biomarkers and Identifying Metabolic Mechanisms in Aging and Alzheimer’s Disease

  2020cites this paper
• Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer’s Disease

  2020cites this paper
• High-Throughput Metabolomics for Discovering Potential Biomarkers and Identifying Metabolic Mechanisms in Aging and Alzheimer’s Disease

  2020influential citation
• 547 transcriptomes from 44 brain areas reveal features of the aging brain in non-human primates

  2019cites this paper
• Mitochondria and Calcium Regulation as Basis of Neurodegeneration Associated With Aging

  2018cites this paper
• Exercise decreases BACE and APP levels in the hippocampus of a rat model of Alzheimer's disease

  2018cites this paper
• Rutin as a Potent Antioxidant: Implications for Neurodegenerative Disorders

  2018cites this paper
• Coordinating Organismal Physiology Through the Unfolded Protein Response

  2018cites this paper
• Novel Modulators of Proteostasis: RNAi Screen of Chromosome I in a Heat Stress Paradigm in C. elegans

  2018cites this paper
• Therapeutic Potential of FGF21 in Alzheimer’s Disease

  2018cites this paper
• ER Stress and Neurodegenerative Disease: A Cause or Effect Relationship?

  2018cites this paper
• Therapeutic Potential of FGF 21 in Alzheimer ’ s Disease

  2017cites this paper
• Neuroprotective effects of N-adamantyl-4-methylthiazol-2-amine against amyloid β-induced oxidative stress in mouse hippocampus.

  2017cites this paper
• Playful Design for Activation: Co-designing serious games for people with moderate to severe dementia to reduce apathy

  2017cites this paper
• Chronic treatment with a smart antioxidative nanoparticle for inhibition of amyloid plaque propagation in Tg2576 mouse model of Alzheimer’s disease

  2017influential citation
• Age-Related Decline in the Variation of Dynamic Functional Connectivity: A Resting State Analysis

  2017cites this paper
• Structure-activity relations of rosmarinic acid derivatives for the amyloid β aggregation inhibition and antioxidant properties.

  2017cites this paper
• Impaired expression of GABA transporters in the human Alzheimer's disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus.

  2017cites this paper
• Differential Phenotypes of Myeloid-Derived Suppressor and T Regulatory Cells and Cytokine Levels in Amnestic Mild Cognitive Impairment Subjects Compared to Mild Alzheimer Diseased Patients

  2017cites this paper
• Aging and Neurodegeneration: A Tangle of Models and Mechanisms

  2016cites this paper
• Ausgewählte altersbedingte Erkrankungen

  2016cites this paper
• Chitosan oligosaccharides alleviate cognitive deficits in an amyloid-β1-42-induced rat model of Alzheimer's disease.

  2016cites this paper
• Protective Effect of Amyloid-β Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model

  2016cites this paper
• Multiple mechanisms of age-dependent accumulation of amyloid beta protein in rat brain: Prevention by dietary supplementation with N-acetylcysteine, α-lipoic acid and α-tocopherol.

  2016cites this paper
• Anti-Viral Properties of Amyloid-β Peptides

  2016cites this paper
• Étude du polymorphisme rs3846662 de l’HMGCR dans le cerveau et le système périphérique

  2016cites this paper
• Maternal inflammation linearly exacerbates offspring age-related changes of spatial learning and memory, and neurobiology until senectitude.

  2016cites this paper
• N-Adamantyl-4-methylthiazol-2-amine suppresses amyloid β-induced neuronal oxidative damage in cortical neurons

  2016cites this paper
• The effect of simvastatin and rosuvastatin on relieving the symptoms of alzheimer's disease in a mouse model

  2016cites this paper
• Observational and Ecological Studies of Dietary Advanced Glycation End Products in National Diets and Alzheimer's Disease Incidence and Prevalence

  2015cites this paper
• NK Cells are Activated in Amnestic Mild Cognitive Impairment but not in Mild Alzheimer’s Disease Patients

  2015cites this paper
• Decrease in catalytic capacity of γ-secretase can facilitate pathogenesis in sporadic and Familial Alzheimer's disease.

  2015influential citation
• Play Experiences for People with Alzheimer's Disease

  2015cites this paper
• Inflammatory risk factors and pathologies promoting Alzheimer's disease progression: is RAGE the key?

  2015cites this paper
• Effects of Long Term Consumption of Animal Proteins in the High Calorie Diet

  2015cites this paper
• High Calorie Diet and the Human Brain

  2015cites this paper
• Play experiences for people with Alzheimer’s disease

  2015cites this paper
• Inactivation of brain Cofilin-1 by age, Alzheimer's disease and γ-secretase.

  2014cites this paper
• Discovery and characterization of novel drugs for Treatment of Alzheimer disease from a high-throughput compound screen

  2014cites this paper
• Decreasing oxidative stress and neuroinflammation with a multifunctional peptide rescues memory deficits in mice with Alzheimer disease.

  2014cites this paper
• Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound.

  2014cites this paper
• Implications of Human Umbilical Cord Blood Cells: An Immunotherapeutic Strategy for Alzheimer's Disease

  2014cites this paper
• Identification of tetrahydrocarbazoles as novel multifactorial drug candidates for treatment of Alzheimer's disease

  2014cites this paper
• Selected Age-Related Disorders

  2014cites this paper
• Cell Aging: Molecular Mechanisms and Implications for Disease

  2013cites this paper
• Carbonyl stress in aging process: role of vitamins and phytochemicals as redox regulators.

  2013cites this paper
• Green tea catechin leads to global improvement among Alzheimer's disease-related phenotypes in NSE/hAPP-C105 Tg mice.

  2013cites this paper
• Aβ increases neural stem cell activity in senescence-accelerated SAMP8 mice.

  2013cites this paper
• Total antioxidant capacity of the diet and major neurologic outcomes in older adults

  2013cites this paper
• Neuropathological diagnosis of alzheimer ' s disease : the relationship between postmortem assessment , cognitive function and functional status in

  2013cites this paper
• Identification and management of cognitive decline in companion animals and the comparisons with Alzheimer disease: A review

  2013cites this paper
• Alzheimer-Demenz und weitere neurodegenerative Erkrankungen

  2012cites this paper
• BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer’s disease

  2012cites this paper
• Amyloid-β Production: Major Link Between Oxidative Stress and BACE1

  2012cites this paper
• Anti-Amyloidogenic Effect of Thiacremonone through Anti-Inflamation In Vitro and In Vivo Models

  2012cites this paper
• The Complexity of Sporadic Alzheimer's Disease Pathogenesis: The Role of RAGE as Therapeutic Target to Promote Neuroprotection by Inhibiting Neurovascular Dysfunction

  2012cites this paper
• COGNITIVE DYSFUNCTION SYNDROME

  2012cites this paper
• Modification of γ-secretase by nitrosative stress links neuronal ageing to sporadic Alzheimer's disease

  2012cites this paper
• Protein Homeostasis, Aging and Alzheimer’s Disease

  2012cites this paper
• Aging is the primary risk factor for the majority of neurodegenerative diseases, including Alzheimer’s disease (AD) and Parkinson’s disease

  2012cites this paper
• Aging-dependent brain electrophysiological effects in rats after distinct lactation conditions, and treadmill exercise: a spreading depression analysis.

  2012cites this paper
• Neuroprotection and Neuroregeneration in Alzheimer's Disease

  2012cites this paper
• The serotonergic system in ageing and Alzheimer's disease.

  2012cites this paper
• Some evolutionary perspectives on Alzheimer's disease pathogenesis and pathology

  2012cites this paper
• Physical exercise as a possible strategy for brain protection: evidence from mitochondrial-mediated mechanisms.

  2012cites this paper
• Rutin inhibits β-amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and proinflammatory cytokines.

  2012cites this paper
• A synthetic amino acid substitution of Tyr10 in Aβ peptide sequence yields a dominant negative variant in amyloidogenesis

  2012cites this paper
• Altered serotonergic neurotransmission as a main player in the pathophysiology of Alzheimer's disease : structural and ultrastructural studies in a triple transgenic mouse model of the disease

  2012cites this paper
• Assessment of In-House Natural Product and Synthetic Compound Libraries Based on In vitro Inhibition of Cholinesterases

  2011cites this paper
• Cerebral Amyloid Angiopathy, Blood-Brain Barrier Disruption and Amyloid Accumulation in SAMP8 Mice

  2011cites this paper
• Epigenetic Enhancement of BDNF Signaling Rescues Synaptic Plasticity in Aging

  2011cites this paper
• Roles of amyloid precursor protein family members in neuroprotection, stress signaling and aging

  2011cites this paper
• Protein Modification by Dicarbonyl Molecular Species in Neurodegenerative Diseases

  2011cites this paper
• Neuropathological diagnosis of Alzheimer's Disease: The relationship between postmortem assessment, cognitive function and functional status in centenarians

  2011cites this paper
• Alzheimer's disease: Cholesterol a menace?

  2011cites this paper
• Therapeutic Approaches to Delay the Onset of Alzheimer's Disease

  2011cites this paper
• Quantification of Volumetric Changes of Brain in Neurodegenerative Diseases Using Magnetic Resonance Imaging and Stereology

  2011cites this paper
• Normalization of gene expression using SYBR green qPCR: a case for paraoxonase 1 and 2 in Alzheimer's disease brains.

  2011cites this paper
• Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration.

  2011cites this paper
• Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk.

  2010cites this paper
• Inflammation and Alzheimer’s disease

  2010cites this paper
• Disruption of blood-brain barrier function by chronic intake of saturated fat and cholesterol : implications for Alzheimer’s disease risk

  2010cites this paper
• Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease.

  2010cites this paper
• Evidence for the involvement of apoptosis-inducing factor-mediated caspase-independent neuronal death in Alzheimer disease.

  2010cites this paper
• Age, Alzheimer's disease and dementia in the Baltimore Longitudinal Study of Ageing.

  2010cites this paper
• Oxidative stress mediates the pathogenic effect of different Alzheimer ’ s disease risk factors

  2010cites this paper
• Protective Role of Methylene Blue in Alzheimer's Disease via Mitochondria and Cytochrome c Oxidase

  2010cites this paper